Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-18 Sale |
2020-08-20 6:23 pm |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
8,054 | $158.17 | $1,273,892 | 190,414 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-17 9:40 pm |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
450 | $157.79 | $71,006 | 155,202 (Direct) |
View |
| 2020-08-10 Sale |
2020-08-13 06:04 am |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $156.74 | $4,463,263 | 776,595 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 7:14 pm |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
20,000 | $165.72 | $3,314,418 | 143,181 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-17 Option Award |
2020-08-18 7:53 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | LOVE TED W Director |
6,259 | $0 | 6,259 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:40 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
45,901 | $0 | 155,202 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:34 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
97,365 | $0 | 815,704 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:32 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
27,123 | $0 | 82,430 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:31 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
30,045 | $0 | 173,226 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:29 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
22,951 | $0 | 214,823 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:27 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | LIU JEAN I GC/EVP, Legal Affairs |
25,036 | $0 | 88,633 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-13 06:04 am |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $12 | 776,595 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-13 06:04 am |
N/A 2020-08-27 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $0 | 776,595 (Direct) |
View |